Bayer 91555 FC Patch-low contraceptive study

Investigator: Philip Darney, MD, MS
Sponsor: Bayer HealthCare Pharmaceuticals, Inc

Location(s): United States


The primary objective of this study was to investigate the contraceptive efficacy of the transdermal contraceptive patch.
The secondary objective was to investigate the safety profile. Compliance and subjective assessment of satisfaction with the transdermal contraceptive patch were also evaluated.